Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.00K | 16.90K | 11.60K | 12.30K | 17.40K |
| Total Other Revenue | -- | -- | -- | 100.00 | 100.00 |
| Total Revenue | 12.00K | 16.90K | 11.60K | 12.30K | 17.40K |
| Cost of Revenue | 377.20K | 369.00K | 347.30K | 348.80K | 365.30K |
| Gross Profit | -365.20K | -352.20K | -335.80K | -336.60K | -348.00K |
| SG&A Expenses | 5.11M | 4.69M | 4.55M | 4.22M | 4.14M |
| Depreciation & Amortization | 1.11M | 1.08M | 1.07M | 1.04M | 509.60K |
| Other Operating Expenses | -343.80K | -259.30K | -271.40K | -299.30K | 285.10K |
| Total Operating Expenses | 18.09M | 17.06M | 15.66M | 14.42M | 12.97M |
| Operating Income | -18.07M | -17.04M | -15.65M | -14.41M | -12.96M |
| Income Before Tax | -16.72M | -16.02M | -14.76M | -14.32M | -13.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.72 | -16.02 | -14.76 | -14.32 | -13.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.72M | -16.02M | -14.76M | -14.32M | -13.10M |
| EBIT | -18.07M | -17.04M | -15.65M | -14.41M | -12.96M |
| EBITDA | -17.47M | -16.47M | -15.10M | -13.88M | -12.45M |
| EPS Basic | -0.16 | -0.16 | -0.15 | -0.15 | -0.15 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.09 | -0.09 | -0.09 |
| EPS Diluted | -0.16 | -0.16 | -0.15 | -0.15 | -0.15 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.09 | -0.09 | -0.09 |
| Average Basic Shares Outstanding | 412.03M | 402.73M | 393.59M | 378.77M | 361.37M |
| Average Diluted Shares Outstanding | 412.03M | 402.73M | 393.59M | 378.77M | 361.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |